Evoke Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-24,240
| Closed | -$5.27M | – | 8 |
|
|
2026
Q1 | $5.27M | Sell |
24,240
-5,717
| -19% | -$1.27M | 0.09% | 87 |
|
|
2025
Q4 | $6.84M | Sell |
29,957
-251
| -0.8% | -$57.2K | 0.13% | 71 |
|
|
2025
Q3 | $6.99M | Buy |
30,208
+1,576
| +6% | +$321K | 0.14% | 66 |
|
|
2025
Q2 | $5.31M | Buy |
28,632
+4,758
| +20% | +$884K | 0.12% | 79 |
|
|
2025
Q1 | $5M | Buy |
23,874
+1,392
| +6% | +$271K | 0.13% | 71 |
|
|
2024
Q4 | $4M | Buy |
22,482
+2,556
| +13% | +$470K | 0.11% | 83 |
|
|
2024
Q3 | $3.94M | Buy |
+19,926
| New | +$3.72M | 0.11% | 83 |
|
|
2024
Q2 | – | Sell |
-19,748
| Closed | -$3.6M | – | 106 |
|
|
2024
Q1 | $3.6M | Buy |
+19,748
| New | +$3.4M | 0.11% | 85 |
|
|
2023
Q4 | – | Sell |
-21,105
| Closed | -$3.15M | – | 95 |
|
|
2023
Q3 | $3.15M | Buy |
21,105
+405
| +2% | +$59.5K | 0.11% | 91 |
|
|
2023
Q2 | $2.79M | Buy |
20,700
+222
| +1% | +$32.6K | 0.1% | 97 |
|
|
2023
Q1 | $3.26M | Buy |
20,478
+337
| +2% | +$51.5K | 0.12% | 86 |
|
|
2022
Q4 | $3.25M | Buy |
20,141
+39
| +0.2% | +$5.98K | 0.12% | 92 |
|
|
2022
Q3 | $2.7M | Buy |
20,102
+10
| +0% | +$1.44K | 0.11% | 89 |
|
|
2022
Q2 | $3.08M | Sell |
20,092
-65
| -0.3% | -$9.93K | 0.11% | 90 |
|
|
2022
Q1 | $3.27M | Sell |
20,157
-2,804
| -12% | -$407K | 0.11% | 93 |
|
|
2021
Q4 | $3.11M | Sell |
22,961
-1,290
| -5% | -$152K | 0.1% | 98 |
|
|
2021
Q3 | $2.62M | Sell |
24,251
-133
| -0.5% | -$15.2K | 0.1% | 106 |
|
|
2021
Q2 | $2.75M | Buy |
24,384
+5,638
| +30% | +$635K | 0.1% | 106 |
|
|
2021
Q1 | $2.03M | Buy |
18,746
+9,491
| +103% | +$1.02M | 0.09% | 113 |
|
|
2020
Q4 | $992K | Buy |
9,255
+743
| +9% | +$71.4K | 0.07% | 98 |
|
|
2020
Q3 | $746K | Buy |
8,512
+115
| +1% | +$10.8K | 0.06% | 103 |
|
|
2020
Q2 | $824K | Buy |
8,397
+3,712
| +79% | +$327K | 0.08% | 79 |
|
|
2020
Q1 | $357K | Sell |
4,685
-3,229
| -41% | -$275K | 0.05% | 125 |
|
|
2019
Q4 | $701K | Buy |
7,914
+394
| +5% | +$32.7K | 0.09% | 106 |
|
|
2019
Q3 | $569K | Buy |
+7,520
| New | +$516K | 0.07% | 138 |
|
Other funds holding ABBV
Evoke Wealth's ABBV Position: Q2 2026 in Review
Evoke Wealth sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 24,240 shares — an estimated $5.27M sold.
Evoke Wealth first reported a position in ABBV in Q3 2019 and held it in 25 quarters. The position peaked at $6.99M in Q3 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Evoke Wealth reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
- Evoke Wealth sold 24,240 AbbVie shares in Q2 2026, an estimated $5.27M.
- Evoke Wealth first reported a position in AbbVie in Q3 2019 and held it in 25 quarters.
- Evoke Wealth's AbbVie position peaked at $6.99M in Q3 2025.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.